The Tripartite Nexus: Autophagy, Cancer, and Tripartite Motif-Containing Protein Family Members
Autophagy is a cellular degradative process that has multiple important actions in cancer. Autophagy modulation is under consideration as a promising new approach to cancer therapy. However, complete autophagy dysregulation is likely to have substantial undesirable side effects. Thus, more targeted...
Main Authors: | Michael A. Mandell, Bhaskar Saha, Todd A. Thompson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00308/full |
Similar Items
-
Selective Autophagy Receptor p62/SQSTM1, a Pivotal Player in Stress and Aging
by: Anita V. Kumar, et al.
Published: (2022-02-01) -
iNOS Interacts with Autophagy Receptor p62 and is Degraded by Autophagy in Macrophages
by: Jing Wang, et al.
Published: (2019-10-01) -
Tripartite motif 21 inhibits proliferation of hepatocellular carcinoma cells through down-regulating autophagy related 4B
by: LI Tao, et al.
Published: (2019-05-01) -
The Autophagy Regulator p62 Controls PTEN-Dependent Ciliogenesis
by: Hyowon Mun, et al.
Published: (2020-06-01) -
Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy
by: Sheng Wang, et al.
Published: (2021-03-01)